22nd Jul 2015 08:10
LONDON (Alliance News) - Regenerative medical devices company Tissue Regenix Group PLC on Wednesday said its TRX Wound Care Inc unit has signed a further regional distribution deal for its DermaPure wound care product in the US.
Tissue Regenix said the deal has been signed with a local surgical and wound care distributor who will cover one of the states in the Novitas Medicare administration jurisdiction. It did not provide any details on which US state this would be.
The partnership is expected to generate USD135,000 for Tissue Regenix over the next 12 months.
"This announcement is another demonstration of the group delivering on its strategy to fully commercialise DermaPure in the United States and highlights the benefits of our hybrid distribution strategy," said Chief Executive Antony Odell.
Tissue shares were up 3.6% to 20.20 pence on Wednesday morning.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Tissue Regenix Group